Hikma Pharmaceuticals (LON:HIK) Stock Passes Above 200 Day Moving Average – Here’s Why

Hikma Pharmaceuticals PLC (LON:HIK)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,922.34 ($23.79) and traded as high as GBX 2,002.90 ($24.79). Hikma Pharmaceuticals shares last traded at GBX 2,002.90 ($24.79), with a volume of 103,513 shares trading hands.

Hikma Pharmaceuticals Stock Down 1.0 %

The business’s 50 day moving average is GBX 1,915.68 and its 200 day moving average is GBX 1,922.73. The company has a debt-to-equity ratio of 55.48, a quick ratio of 1.27 and a current ratio of 1.66. The stock has a market cap of £4.42 billion, a price-to-earnings ratio of 3,066.15, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.